SCHEMBL4299815

SCHEMBL4299815

Nc1ccc(Oc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)cc1N

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 9/20 0.45
THRA P10827 8/20 0.45
KDM4E B2RXH2 2/20 0.44
MAPT P10636 1/20 0.44
HIF1A Q16665 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
SLC22A8 Q8TCC7 1/20 0.44
ATM Q13315 1/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
HPGD P15428 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 1/20 0.40
EGLN1 Q9GZT9 1/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
NR4A1 P22736 1/20 0.39
LMNA P02545 1/20 0.39
MMP1 P03956 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4299281 0.79 THRB (0.43) THRBTHRANR4A1LMNA
SCHEMBL4347988 0.78 THRA (0.74) THRBTHRA
SCHEMBL5859435 0.78 THRB (0.60) THRBTHRA
SCHEMBL3919564 0.78 THRA (0.47) THRBTHRAKDM4ESMN1; SMN2ALDH1A1
SCHEMBL3137803 0.75 KDM4E (0.51) THRBTHRAKDM4EMAPTHIF1A
SCHEMBL4298109 0.74 GAA (0.43) KDM4EMAPTHPGDSMN1; SMN2ALDH1A1
SCHEMBL3137311 0.74 THRB (0.42) THRBTHRAKDM4EHPGDSMN1; SMN2
SCHEMBL5619110 0.73 THRB (0.65) THRBTHRAHIF1ACA1CA2
SCHEMBL3141209 0.73 THRB (0.46) THRBTHRAEGLN1
Alanine SCHEMBL5073599 0.72 THRB (0.41) THRBTHRAEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318514-A1 Novel Pharmaceutical Compositions KARO BIO AB (SE) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318514-A1 Novel Pharmaceutical Compositions TSHR, TRHR, THRA THRB 5/4885THRA 3/4885KDM4E 1775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.